drugset
drugset / Trial / NCT06783192

A Drug-Drug Interaction Study of MK 8527 With a Combined Oral Contraceptive (LNG/EE)

NCT06783192 ↗

Phase 1 Completed 14 enrolled Merck Sharp & Dohme LLC
NaSingle-groupOpen-labelPrevention

Summary

This study is designed to assess the effect of a single dose of MK-8527 on the single-dose pharmacokinetics (PK) and the safety and tolerability of levonorgestrel/ethinyl estradiol (LNG/EE) in healthy adult postmenopausal or ovariectomized female participants.

Timeline

Start
2023-08-14
Primary completion
2023-10-11
Completion
2023-10-11

Drugs

EvaluationDrugModalityDoseRoute
Subject LNG/EE Unknown — Oral
Subject MK-8527 Small molecule — Oral

Indications

HIV infectious disease